G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 26,599 | 2,140 | 0 | 0 | 0 |
| Gross Profit | 26,599 | 2,140 | N/A | N/A | N/A |
| Operating Expenses | 36,344 | 32,962 | 31,821 | 36,553 | 34,024 |
| Operating Income | -9,745 | -30,822 | -31,821 | -36,553 | -34,024 |
| Interest Expense | 757 | 265 | 0 | 0 | 0 |
| Other Income | -241 | -123 | 798 | 1,112 | 1,660 |
| Pre-tax Income | -10,743 | -31,210 | -31,023 | -35,441 | -32,364 |
| Income Tax | 931 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -11,674 | -31,210 | -31,023 | -35,441 | -32,364 |
| Net Income | $-11,674 | $-31,210 | $-31,023 | $-35,441 | $-32,364 |
| EPS Basic Total Ops | -0.31 | -0.83 | -0.82 | -0.95 | -0.86 |
| EPS Basic Continuous Ops | -0.31 | -0.83 | -0.82 | -0.94 | -0.86 |
| EPS Diluted Total Ops | -0.31 | -0.83 | -0.82 | -0.95 | -0.86 |
| EPS Diluted Continuous Ops | -0.31 | -0.83 | -0.82 | -0.94 | -0.86 |
| EBITDA(a) | $-9,337 | $-30,576 | $-31,662 | $-36,412 | $-33,938 |